DNAM-1 expression was next interrogated in relation to disease stage (Figure 5B) and increased expression was seen on blood NK cells in both stage III and IV disease (p=0.0027 and p=0.0004, respectively), together with increased expression within tumour in stage IV metastasis (p=0.0097). Here, CD226 is linked to neoplasm.